Newborn Screening Market Size, Share & Trends Analysis Report By Product, By Technology, By Test Type, By Region, and Segment Forecasts, 2025

The global newborn screening market size was estimated at USD 900.63 million in 2024 and is projected to reach USD 1,797.38 million by 2033, growing at a CAGR of 8.1% from 2025 to 2033. The rising neonatal population, increasing cases of congenital diseases in newborns, growing consumer awareness, and favorable initiatives & support from various governments, which are organizing several programs & legislations, are factors estimated to propel the market over the forecast period.

According to the United Nations Department of Economic and Social Affairs (UN DESA) World Population Prospects 2024, the global number of births remains high, with an estimated 132.4 million babies born worldwide in 2024. Moreover, according to the World Health Organization (WHO), congenital disorders - structural or functional anomalies that occur during intra-uterine life - affect an estimated 6% of all births worldwide. In a more detailed assessment, a global, regional, and national epidemiology study of congenital disabilities found that in 2021, about 31.64 million children (aged 0-14 years) were living with congenital disabilities, representing a 6.68% increase since 1990. In addition, technological advancements in screening methodologies are also expected to boost the market. For instance, in November 2023, Revvity, Inc. (US) launched its EONIS Q system, a CE-IVD declared platform enabling laboratories in countries that accept the CE marking to adopt molecular testing for spinal muscular atrophy (SMA) and severe combined immunodeficiency (SCID) in newborns.

Furthermore, extensively increasing prevalence of congenital diseases in newborns is expected to have a positive impact on the newborn screening market growth. According to data published by WHO in February 2023, an estimated 240,000 newborns within 28 days of birth die each year globally due to congenital diseases. Congenital disorders are further responsible for an estimated 170, 000 child deaths in the age group of 1 month to 5 years. In addition, according to information from Indian Pediatrics, congenital hypothyroidism occurs in 2.1 out of every 1,000 infants in India, and the prevalence of inborn metabolic abnormalities ranges from 2 to 7.8%. Such a substantial occurrence of congenital diseases amongst newborns is likely to increase the adoption of tests, which is expected to accelerate the market growth by 2030.

In addition, the introduction of government programs and legislation is also expected to offer a favorable environment for newborn screening market growth. Programs around the globe bring newborn screening into the Genome Era. For instance, in 2023, an anticipated 100,000 infants participated in an NGS newborn screening pilot program. Illumina has participated in at least nine large-scale national and international genomic NBS investigations, screening up to 40,000 babies. This includes GUARDIAN in the U.S., Generation Study in the United Kingdom, BabyScreen+ in Australia, and BabyDetect in Belgium.

The demand for newborn procedures is expected to be influenced by the introduction of new technologies and the availability of treatment options enabling the diagnosis of about 29 possible disorders, such as galactosemia (GS), phenylketonuria (PKU), hearing disorders, and congenital hypothyroidism (CH) in neonates. In March 2023, a group of scientists at the Division of Laboratory Sciences, CDC, announced the introduction of improved tests that offer advanced technology for the diagnosis of genetic diseases.

Global Newborn Screening Market Report Segmentation

This report forecasts revenue growth and provides an analysis on the latest trends in each of the sub-segments from 2021 to 2033. For this report, Grand View Research has segmented the newborn screening market based on product, technology, test type, and region:

Product Outlook (Revenue, USD Million, 2021 - 2033)
Instruments
Reagents
Technology Outlook (Revenue, USD Million, 2021 - 2033)
Tandem mass spectrometry
Pulse oximetry
Enzyme based assay
DNA assay
Electrophoresis
Others
Test Type Outlook (Revenue, USD Million, 2021 - 2033)
Dry blood spot test
CCHD
Hearing screen
Regional Outlook (Revenue, USD Million, 2021 - 2033)
North America
- U.S.
- Canada
- Mexico
Europe
- Germany
- UK
- France
- Italy
- Spain
- Denmark
- Sweden
- Norway
Asia Pacific
- Japan
- China
- India
- Australia
- South Korea
- Thailand
- South Korea
Latin America
- Brazil
- Argentina
Middle East and Africa (MEA)
- South Africa
- Saudi Arabia
- UAE
- Kuwait

Product Code: 978-1-68038-490-1

Chapter 1. Newborn Screening Market: Methodology and Scope

1.1. Market Segmentation and Scope
- 1.1.1. Segment Definitions
  - 1.1.1.1. Product Method
  - 1.1.1.2. Technology Segment
  - 1.1.1.3. Test Type Segment
1.2. Regional Scope
1.3. Estimates and Forecast Timeline
1.4. Objectives
- 1.4.1. Objective - 1
- 1.4.2. Objective - 2
- 1.4.3. Objective - 3
1.5. Research Methodology
1.6. Information Procurement
- 1.6.1. Purchased Database
- 1.6.2. GVR's Internal Database
- 1.6.3. Secondary Sources
- 1.6.4. Primary Research
1.7. Information or Data Analysis
- 1.7.1. Data Analysis Models
1.8. Market Formulation & Validation
1.9. Model Details
- 1.9.1. Commodity Flow Analysis
1.10. List of Secondary Sources
1.11. List of Abbreviations

Chapter 2. Newborn Screening Market: Executive Summary

2.1. Market Snapshot
2.2. Product Snapshot
2.3. Technology Snapshot
2.4. Test Type Snapshot
2.5. Competitive Landscape Snapshot

Chapter 3. Newborn Screening Market Variables, Trends, & Scope

3.1. Market Segmentation and Scope
3.2. Market Lineage Outlook
- 3.2.1. Parent Market Outlook
- 3.2.2. Related/Ancillary Market Outlook
3.3. Market Dynamics
3.4. Market Drivers Analysis
- 3.4.1. Rising neonatal population
- 3.4.2. Increasing cases of congenital diseases in newborns
- 3.4.3. Growing consumer awareness, and favorable initiatives
- 3.4.4. Support from various governments organizing several programs & legislations
3.5. Market Restraint Analysis
- 3.5.1. High costs and limited accessibility
- 3.5.2. Infrastructure and skilled workforce deficiencies
- 3.5.3. Variations in screening practices
3.6. Porter's Five Forces Analysis
3.7. PESTLE Analysis
3.8. Pipeline Analysis

Chapter 4. Newborn Screening Market: Product Estimates & Trend Analysis

4.1. Newborn Screening Market: Product Movement Analysis
4.2. Instruments
- 4.2.1. Instruments market, 2021 - 2033 (USD Million)
4.3. Reagents
- 4.3.1. Reagents market, 2021 - 2033 (USD Million)

Chapter 5. Newborn Screening Market: Technology Estimates & Trend Analysis

5.1. Newborn Screening Market: Technology Movement Analysis
5.2. Tandem mass spectrometry
- 5.2.1. Tandem mass spectrometry market, 2021 - 2033 (USD Million)
5.3. Pulse oximetry
- 5.3.1. Pulse oximetry market, 2021 - 2033 (USD Million)
5.4. Enzyme based assay
- 5.4.1. Enzyme based assays market, 2021 - 2033 (USD Million)
5.5. DNA assays
- 5.5.1. DNA assays market, 2021 - 2033 (USD Million)
5.6. Electrophoresis
- 5.6.1. Electrophoresis market, 2021 - 2033 (USD Million)

Chapter 6. Newborn Screening Market: Test Type Estimates & Trend Analysis

6.1. Newborn Screening Market: Test Type Movement Analysis
6.2. Dry blood spot test
- 6.2.1. Dry blood spot test market, 2021 - 2033 (USD Million)
6.3. CCHD
- 6.3.1. CCHD test market, 2021 - 2033 (USD Million)
6.4. Hearing screen
- 6.4.1. Hearing screen test market, 2021 - 2033 (USD Million)

Chapter 7. Newborn Screening Market: Regional Business Analysis

7.1. Regional Market Snapshot
7.2. North America
- 7.2.1. North America Newborn Screening Market Estimates and Forecast, 2021 - 2033 (USD Million)
- 7.2.2. U.S.
  - 7.2.2.1. U.S. Newborn Screening Market, 2021 - 2033 (USD Million)
  - 7.2.2.2. Key Country Dynamics
  - 7.2.2.3. Regulatory Framework
  - 7.2.2.4. Reimbursement Scenario
  - 7.2.2.5. Competitive Scenario
- 7.2.3. Canada
  - 7.2.3.1. Canada Newborn Screening Market, 2021 - 2033 (USD Million)
  - 7.2.3.2. Key Country Dynamics
  - 7.2.3.3. Regulatory Framework
  - 7.2.3.4. Reimbursement Scenario
  - 7.2.3.5. Competitive Scenario
- 7.2.4. Mexico
  - 7.2.4.1. Mexico Newborn Screening Market, 2021 - 2033 (USD Million)
  - 7.2.4.2. Key Country Dynamics
  - 7.2.4.3. Regulatory Framework
  - 7.2.4.4. Reimbursement Scenario
  - 7.2.4.5. Competitive Scenario
7.3. Europe
- 7.3.1. Europe Newborn Screening Market, 2021 - 2033 (USD Million)
- 7.3.2. UK
  - 7.3.2.1. UK Newborn Screening Market, 2021 - 2033 (USD Million)
  - 7.3.2.2. Key Country Dynamics
  - 7.3.2.3. Regulatory Framework
  - 7.3.2.4. Reimbursement Scenario
  - 7.3.2.5. Competitive Scenario
- 7.3.3. Germany
  - 7.3.3.1. Germany Newborn Screening Market, 2021 - 2033 (USD Million)
  - 7.3.3.2. Key Country Dynamics
  - 7.3.3.3. Regulatory Framework
  - 7.3.3.4. Reimbursement Scenario
  - 7.3.3.5. Competitive Scenario
- 7.3.4. Spain
  - 7.3.4.1. Spain Newborn Screening Market, 2021 - 2033 (USD Million)
  - 7.3.4.2. Key Country Dynamics
  - 7.3.4.3. Regulatory Framework
  - 7.3.4.4. Reimbursement Scenario
  - 7.3.4.5. Competitive Scenario
- 7.3.5. France
  - 7.3.5.1. France Newborn Screening Market, 2021 - 2033 (USD Million)
  - 7.3.5.2. Key Country Dynamics
  - 7.3.5.3. Regulatory Framework
  - 7.3.5.4. Reimbursement Scenario
  - 7.3.5.5. Competitive Scenario
- 7.3.6. Italy
  - 7.3.6.1. Italy Newborn Screening Market, 2021 - 2033 (USD Million)
  - 7.3.6.2. Key Country Dynamics
  - 7.3.6.3. Regulatory Framework
  - 7.3.6.4. Reimbursement Scenario
  - 7.3.6.5. Competitive Scenario
- 7.3.7. Denmark
  - 7.3.7.1. Denmark Newborn Screening Market, 2021 - 2033 (USD Million)
  - 7.3.7.2. Key Country Dynamics
  - 7.3.7.3. Regulatory Framework
  - 7.3.7.4. Reimbursement Scenario
  - 7.3.7.5. Competitive Scenario
- 7.3.8. Sweden
  - 7.3.8.1. Sweden Newborn Screening Market, 2021 - 2033 (USD Million)
  - 7.3.8.2. Key Country Dynamics
  - 7.3.8.3. Regulatory Framework
  - 7.3.8.4. Reimbursement Scenario
  - 7.3.8.5. Competitive Scenario
- 7.3.9. Norway
  - 7.3.9.1. Norway Newborn Screening Market, 2021 - 2033 (USD Million)
  - 7.3.9.2. Key Country Dynamics
  - 7.3.9.3. Regulatory Framework
  - 7.3.9.4. Reimbursement Scenario
  - 7.3.9.5. Competitive Scenario
7.4. Asia Pacific
- 7.4.1. Asia-Pacific Newborn Screening Market, 2021 - 2033 (USD Million)
- 7.4.2. Japan
  - 7.4.2.1. Japan Newborn Screening Market, 2021 - 2033 (USD Million)
  - 7.4.2.2. Key Country Dynamics
  - 7.4.2.3. Regulatory Framework
  - 7.4.2.4. Reimbursement Scenario
  - 7.4.2.5. Competitive Scenario
- 7.4.3. China
  - 7.4.3.1. China Newborn Screening Market, 2021 - 2033 (USD Million)
  - 7.4.3.2. Key Country Dynamics
  - 7.4.3.3. Regulatory Framework
  - 7.4.3.4. Reimbursement Scenario
  - 7.4.3.5. Competitive Scenario
- 7.4.4. India
  - 7.4.4.1. India Newborn Screening Market, 2021 - 2033 (USD Million)
  - 7.4.4.2. Key Country Dynamics
  - 7.4.4.3. Regulatory Framework
  - 7.4.4.4. Reimbursement Scenario
  - 7.4.4.5. Competitive Scenario
- 7.4.5. South Korea
  - 7.4.5.1. South Korea Newborn Screening Market, 2021 - 2033 (USD Million)
  - 7.4.5.2. Key Country Dynamics
  - 7.4.5.3. Regulatory Framework
  - 7.4.5.4. Reimbursement Scenario
  - 7.4.5.5. Competitive Scenario
- 7.4.6. Thailand
  - 7.4.6.1. Thailand Newborn Screening Market, 2021 - 2033 (USD Million)
  - 7.4.6.2. Key Country Dynamics
  - 7.4.6.3. Regulatory Framework
  - 7.4.6.4. Reimbursement Scenario
  - 7.4.6.5. Competitive Scenario
- 7.4.7. Australia
  - 7.4.7.1. Australia Newborn Screening Market, 2021 - 2033 (USD Million)
  - 7.4.7.2. Key Country Dynamics
  - 7.4.7.3. Regulatory Framework
  - 7.4.7.4. Reimbursement Scenario
  - 7.4.7.5. Competitive Scenario
7.5. Latin America
- 7.5.1. Latin America Newborn Screening Market, 2021 - 2033 (USD Million)
- 7.5.2. Brazil
  - 7.5.2.1. Brazil Newborn Screening Market, 2021 - 2033 (USD Million)
  - 7.5.2.2. Key Country Dynamics
  - 7.5.2.3. Regulatory Framework
  - 7.5.2.4. Reimbursement Scenario
  - 7.5.2.5. Competitive Scenario
- 7.5.3. Argentina
  - 7.5.3.1. Argentina Newborn Screening Market, 2021 - 2033 (USD Million)
  - 7.5.3.2. Key Country Dynamics
  - 7.5.3.3. Regulatory Framework
  - 7.5.3.4. Reimbursement Scenario
  - 7.5.3.5. Competitive Scenario
7.6. MEA
- 7.6.1. MEA Newborn Screening Market, 2021 - 2033 (USD Million)
- 7.6.2. South Africa
  - 7.6.2.1. South Africa Newborn Screening Market, 2021 - 2033 (USD Million)
  - 7.6.2.2. Key Country Dynamics
  - 7.6.2.3. Regulatory Framework
  - 7.6.2.4. Reimbursement Scenario
  - 7.6.2.5. Competitive Scenario
- 7.6.3. Saudi Arabia
  - 7.6.3.1. Saudi Arabia Newborn Screening Market, 2021 - 2033 (USD Million)
  - 7.6.3.2. Key Country Dynamics
  - 7.6.3.3. Regulatory Framework
  - 7.6.3.4. Reimbursement Scenario
  - 7.6.3.5. Competitive Scenario
- 7.6.4. UAE
  - 7.6.4.1. UAE Newborn Screening Market, 2021 - 2033 (USD Million)
  - 7.6.4.2. Key Country Dynamics
  - 7.6.4.3. Regulatory Framework
  - 7.6.4.4. Reimbursement Scenario
  - 7.6.4.5. Competitive Scenario
- 7.6.5. Kuwait
  - 7.6.5.1. Kuwait Newborn Screening Market, 2021 - 2033 (USD Million)
  - 7.6.5.2. Key Country Dynamics
  - 7.6.5.3. Regulatory Framework
  - 7.6.5.4. Reimbursement Scenario
  - 7.6.5.5. Competitive Scenario

Chapter 8. Competitive Landscape

8.1. Company Categorization
8.2. Strategy Mapping
- 8.2.1. New Product Launch
- 8.2.2. Partnerships
- 8.2.3. Acquisition
- 8.2.4. Collaboration
- 8.2.5. Funding
8.3. Key Company Market Share Analysis, 2024
8.4. Company Heat Map Analysis
8.5. Company Profiles
- 8.5.1. Bio-Rad Laboratories
  - 8.5.1.1. Overview
  - 8.5.1.2. Financial Performance
  - 8.5.1.3. Product Benchmarking
  - 8.5.1.4. Strategic Initiatives
- 8.5.2. Agilent Technologies
  - 8.5.2.1. Overview
  - 8.5.2.2. Financial Performance
  - 8.5.2.3. Product Benchmarking
  - 8.5.2.4. Strategic Initiatives
- 8.5.3. Masimo
  - 8.5.3.1. Overview
  - 8.5.3.2. Financial Performance
  - 8.5.3.3. Product Benchmarking
  - 8.5.3.4. Strategic Initiatives
- 8.5.4. Waters Corporation
  - 8.5.4.1. Overview
  - 8.5.4.2. Financial Performance
  - 8.5.4.3. Product Benchmarking
  - 8.5.4.4. Strategic Initiatives
- 8.5.5. Natus Medical
  - 8.5.5.1. Overview
  - 8.5.5.2. Financial Performance
  - 8.5.5.3. Product Benchmarking
  - 8.5.5.4. Strategic Initiatives
- 8.5.6. Trivitron Healthcare
  - 8.5.6.1. Overview
  - 8.5.6.2. Financial Performance
  - 8.5.6.3. Product Benchmarking
  - 8.5.6.4. Strategic Initiatives
- 8.5.7. GE Lifesciences
  - 8.5.7.1. Overview
  - 8.5.7.2. Financial Performance
  - 8.5.7.3. Product Benchmarking
  - 8.5.7.4. Strategic Initiatives
- 8.5.8. PerkinElmer Inc
  - 8.5.8.1. Overview
  - 8.5.8.2. Financial Performance
  - 8.5.8.3. Product Benchmarking
  - 8.5.8.4. Strategic Initiatives
- 8.5.9. AB SCIEX
  - 8.5.9.1. Overview
  - 8.5.9.2. Financial Performance
  - 8.5.9.3. Product Benchmarking
  - 8.5.9.4. Strategic Initiatives
- 8.5.10. Demand A/S
  - 8.5.10.1. Overview
  - 8.5.10.2. Financial Performance
  - 8.5.10.3. Product Benchmarking
  - 8.5.10.4. Strategic Initiatives
- 8.5.11. Parseq LAB
  - 8.5.11.1. Overview
  - 8.5.11.2. Financial Performance
  - 8.5.11.3. Product Benchmarking
  - 8.5.11.4. Strategic Initiatives
- 8.5.12. Otodynamics
  - 8.5.12.1. Overview
  - 8.5.12.2. Financial Performance
  - 8.5.12.3. Product Benchmarking
  - 8.5.12.4. Strategic Initiatives
- 8.5.13. Zentech
  - 8.5.13.1. Overview
  - 8.5.13.2. Financial Performance
  - 8.5.13.3. Product Benchmarking
  - 8.5.13.4. Strategic Initiatives
- 8.5.14. Centogene
  - 8.5.14.1. Overview
  - 8.5.14.2. Financial Performance
  - 8.5.14.3. Product Benchmarking
  - 8.5.14.4. Strategic Initiatives

Product Code: 978-1-68038-490-1

List of Tables

Table 1 List of Secondary Sources
Table 2 List of Abbreviation
Table 3 Global Newborn Screening Market, By Region, 2021 - 2033 (USD Million)
Table 4 Global Newborn Screening Market, By Product, 2021 - 2033 (USD Million)
Table 5 Global Newborn Screening Market, By Technology, 2021 - 2033 (USD Million)
Table 6 Global Newborn Screening Market, By Test Type, 2021 - 2033 (USD Million)
Table 7 North America Newborn Screening Market, By Country, 2021 - 2033 (USD Million)
Table 8 North America Newborn Screening Market, By Product, 2021 - 2033 (USD Million)
Table 9 North America Newborn Screening Market, By Technology, 2021 - 2033 (USD Million)
Table 10 North America Newborn Screening Market, By Test Type, 2021 - 2033 (USD Million)
Table 11 U.S. Newborn Screening Market, By Product, 2021 - 2033 (USD Million)
Table 12 U.S. Newborn Screening Market, By Technology, 2021 - 2033 (USD Million)
Table 13 U.S. Newborn Screening Market, By Test Type, 2021 - 2033 (USD Million)
Table 14 Canada Newborn Screening Market, By Product, 2021 - 2033 (USD Million)
Table 15 Canada Newborn Screening Market, By Technology, 2021 - 2033 (USD Million)
Table 16 Canada Newborn Screening Market, By Test Type, 2021 - 2033 (USD Million)
Table 17 Europe Newborn Screening Market, By Country, 2021 - 2033 (USD Million)
Table 18 Europe Newborn Screening Market, By Product, 2021 - 2033 (USD Million)
Table 19 Europe Newborn Screening Market, By Technology, 2021 - 2033 (USD Million)
Table 20 Europe Newborn Screening Market, By Test Type, 2021 - 2033 (USD Million)
Table 21 UK Newborn Screening Market, By Product, 2021 - 2033 (USD Million)
Table 22 UK Newborn Screening Market, By Technology, 2021 - 2033 (USD Million)
Table 23 UK Newborn Screening Market, By Test Type, 2021 - 2033 (USD Million)
Table 24 Germany Newborn Screening Market, By Product, 2021 - 2033 (USD Million)
Table 25 Germany Newborn Screening Market, By Technology, 2021 - 2033 (USD Million)
Table 26 Germany Newborn Screening Market, By Test Type, 2021 - 2033 (USD Million)
Table 27 France Newborn Screening Market, By Product, 2021 - 2033 (USD Million)
Table 28 France Newborn Screening Market, By Technology, 2021 - 2033 (USD Million)
Table 29 France Newborn Screening Market, By Test Type, 2021 - 2033 (USD Million)
Table 30 Italy Newborn Screening Market, By Product, 2021 - 2033 (USD Million)
Table 31 Italy Newborn Screening Market, By Technology, 2021 - 2033 (USD Million)
Table 32 Italy Newborn Screening Market, By Test Type, 2021 - 2033 (USD Million)
Table 33 Spain Newborn Screening Market, By Product, 2021 - 2033 (USD Million)
Table 34 Spain Newborn Screening Market, By Technology, 2021 - 2033 (USD Million)
Table 35 Spain Newborn Screening Market, By Test Type, 2021 - 2033 (USD Million)
Table 36 Denmark Newborn Screening Market, By Product, 2021 - 2033 (USD Million)
Table 37 Denmark Newborn Screening Market, By Technology, 2021 - 2033 (USD Million)
Table 38 Denmark Newborn Screening Market, By Test Type, 2021 - 2033 (USD Million)
Table 39 Sweden Newborn Screening Market, By Product, 2021 - 2033 (USD Million)
Table 40 Sweden Newborn Screening Market, By Technology, 2021 - 2033 (USD Million)
Table 41 Sweden Newborn Screening Market, By Test Type, 2021 - 2033 (USD Million)
Table 42 Norway Newborn Screening Market, By Product, 2021 - 2033 (USD Million)
Table 43 Norway Newborn Screening Market, By Technology, 2021 - 2033 (USD Million)
Table 44 Norway Newborn Screening Market, By Test Type, 2021 - 2033 (USD Million)
Table 45 Asia Pacific Newborn Screening Market, By Country, 2021 - 2033 (USD Million)
Table 46 Asia Pacific Newborn Screening Market, By Product, 2021 - 2033 (USD Million)
Table 47 Asia Pacific Newborn Screening Market, By Technology, 2021 - 2033 (USD Million)
Table 48 Asia Pacific Newborn Screening Market, By Test Type, 2021 - 2033 (USD Million)
Table 49 Japan Newborn Screening Market, By Product, 2021 - 2033 (USD Million)
Table 50 Japan Newborn Screening Market, By Technology, 2021 - 2033 (USD Million)
Table 51 Japan Newborn Screening Market, By Test Type, 2021 - 2033 (USD Million)
Table 52 China Newborn Screening Market, By Product, 2021 - 2033 (USD Million)
Table 53 China Newborn Screening Market, By Technology, 2021 - 2033 (USD Million)
Table 54 China Newborn Screening Market, By Test Type, 2021 - 2033 (USD Million)
Table 55 India Newborn Screening Market, By Product, 2021 - 2033 (USD Million)
Table 56 India Newborn Screening Market, By Technology, 2021 - 2033 (USD Million)
Table 57 India Newborn Screening Market, By Test Type, 2021 - 2033 (USD Million)
Table 58 Australia Newborn Screening Market, By Product, 2021 - 2033 (USD Million)
Table 59 Australia Newborn Screening Market, By Technology, 2021 - 2033 (USD Million)
Table 60 Australia Newborn Screening Market, By Test Type, 2021 - 2033 (USD Million)
Table 61 South Korea Newborn Screening Market, By Product, 2021 - 2033 (USD Million)
Table 62 South Korea Newborn Screening Market, By Technology, 2021 - 2033 (USD Million)
Table 63 South Korea Newborn Screening Market, By Test Type, 2021 - 2033 (USD Million)
Table 64 Thailand Newborn Screening Market, By Product, 2021 - 2033 (USD Million)
Table 65 Thailand Newborn Screening Market, By Technology, 2021 - 2033 (USD Million)
Table 66 Thailand Newborn Screening Market, By Test Type, 2021 - 2033 (USD Million)
Table 67 Latin America Newborn Screening Market, By Country, 2021 - 2033 (USD Million)
Table 68 Latin America Newborn Screening Market, By Product, 2021 - 2033 (USD Million)
Table 69 Latin America Newborn Screening Market, By Technology, 2021 - 2033 (USD Million)
Table 70 Latin America Newborn Screening Market, By Test Type, 2021 - 2033 (USD Million)
Table 71 Brazil Newborn Screening Market, By Product, 2021 - 2033 (USD Million)
Table 72 Brazil Newborn Screening Market, By Technology, 2021 - 2033 (USD Million)
Table 73 Brazil Newborn Screening Market, By Test Type, 2021 - 2033 (USD Million)
Table 74 Mexico Newborn Screening Market, By Product, 2021 - 2033 (USD Million)
Table 75 Mexico Newborn Screening Market, By Technology, 2021 - 2033 (USD Million)
Table 76 Mexico Newborn Screening Market, By Test Type, 2021 - 2033 (USD Million)
Table 77 Argentina Newborn Screening Market, By Product, 2021 - 2033 (USD Million)
Table 78 Argentina Newborn Screening Market, By Test Type, 2021 - 2033 (USD Million)
Table 79 MEA Newborn Screening Market, By Country, 2021 - 2033 (USD Million)
Table 80 MEA Newborn Screening Market, By Product, 2021 - 2033 (USD Million)
Table 81 MEA Newborn Screening Market, By Technology, 2021 - 2033 (USD Million)
Table 82 MEA Newborn Screening Market, By Test Type, 2021 - 2033 (USD Million)
Table 83 South Africa Newborn Screening Market, By Product, 2021 - 2033 (USD Million)
Table 84 South Africa Newborn Screening Market, By Technology, 2021 - 2033 (USD Million)
Table 85 South Africa Newborn Screening Market, By Test Type, 2021 - 2033 (USD Million)
Table 86 Saudi Arabia Newborn Screening Market, By Product, 2021 - 2033 (USD Million)
Table 87 Saudi Arabia Newborn Screening Market, By Technology, 2021 - 2033 (USD Million)
Table 88 Saudi Arabia Newborn Screening Market, By Test Type, 2021 - 2033 (USD Million)
Table 89 UAE Newborn Screening Market, By Product, 2021 - 2033 (USD Million)
Table 90 UAE Newborn Screening Market, By Technology, 2021 - 2033 (USD Million)
Table 91 UAE Newborn Screening Market, By Test Type, 2021 - 2033 (USD Million)
Table 92 Kuwait Newborn Screening Market, By Product, 2021 - 2033 (USD Million)
Table 93 Kuwait Newborn Screening Market, By Technology, 2021 - 2033 (USD Million)
Table 94 Kuwait Newborn Screening Market, By Test Type, 2021 - 2033 (USD Million)

List of Figures

Fig. 1 Newborn Screening Market segmentation
Fig. 2 Market research process
Fig. 3 Data triangulation techniques
Fig. 4 Primary research pattern
Fig. 5 Market research approaches
Fig. 6 Value-chain-based sizing & forecasting
Fig. 7 QFD modelling for market share assessment.
Fig. 8 Market formulation & validation
Fig. 9 Newborn Screening Market snapshot
Fig. 10 Parent market outlook
Fig. 11 Related/ancillary market outlook.
Fig. 12 Penetration and growth prospect mapping
Fig. 13 Newborn Screening Market driver impact
Fig. 14 Newborn Screening Market restraint impact
Fig. 15 SWOT analysis, by factor (political & legal, economic, and technological)
Fig. 16 Industry Analysis - Porter's
Fig. 17 Strategy mapping
Fig. 18 Newborn Screening Market: Product outlook and key takeaways
Fig. 19 Newborn Screening Market: Product movement analysis & market share 2024 & 2030
Fig. 20 Products Market Estimates and Forecast, 2021 - 2033 (USD Million)
Fig. 21 Instruments Market Estimates and Forecast, 2021 - 2033 (USD Million)
Fig. 22 Reagents & Assay Kits Market Estimates and Forecast, 2021 - 2033 (USD Million)
Fig. 23 Newborn Screening Market: Technology outlook and key takeaways
Fig. 24 Newborn Screening Market: Technology movement analysis & market share 2024 & 2030
Fig. 25 Tandem Mass Spectrometry Newborn Screening Market Estimates and Forecast, 2021 - 2033 (USD Million)
Fig. 26 Pulse Oximetry Newborn Screening Market Estimates and Forecast, 2021 - 2033 (USD Million)
Fig. 27 Enzyme Based Assays Newborn Screening Market Estimates and Forecast, 2021 - 2033 (USD Million)
Fig. 28 DNA Assays Newborn Screening Market Estimates and Forecast, 2021 - 2033 (USD Million)
Fig. 29 Electrophoresis Newborn Screening Market Estimates and Forecast, 2021 - 2033 (USD Million)
Fig. 30 Newborn Screening Market: Technology outlook and key takeaways
Fig. 31 Newborn Screening Market: Technology movement analysis & market share 2024 & 2030
Fig. 32 Dry Blood Spot Test Newborn Screening Market Estimates and Forecast, 2021 - 2033 (USD Million)
Fig. 33 Critical Congenital Heart Disease (CCHD) Newborn Screening Market Estimates and Forecast, 2021 - 2033 (USD Million)
Fig. 34 Hearing Screen Newborn Screening Market Estimates and Forecast, 2021 - 2033 (USD Million)
Fig. 35 Regional marketplace: Key takeaways
Fig. 36 Global Newborn Screening Market: Regional movement analysis
Fig. 37 U.S. Market Estimates and Forecast, 2021 - 2033 (USD Million)
Fig. 38 Canada Market Estimates and Forecast, 2021 - 2033 (USD Million)
Fig. 39 Mexico Market Estimates and Forecast, 2021 - 2033 (USD Million)
Fig. 40 Europe Market Estimates and Forecast, 2021 - 2033 (USD Million)
Fig. 41 UK Market Estimates and Forecast, 2021 - 2033 (USD Million)
Fig. 42 Germany Market Estimates and Forecast, 2021 - 2033 (USD Million)
Fig. 43 France Market Estimates and Forecast, 2021 - 2033 (USD Million)
Fig. 44 Italy Market Estimates and Forecast, 2021 - 2033 (USD Million)
Fig. 45 Spain Market Estimates and Forecast, 2021 - 2033 (USD Million)
Fig. 46 Denmark Market Estimates and Forecast, 2021 - 2033 (USD Million)
Fig. 47 Sweden Market Estimates and Forecast, 2021 - 2033 (USD Million)
Fig. 48 Norway Market Estimates and Forecast, 2021 - 2033 (USD Million)
Fig. 49 Asia-Pacific Market Estimates and Forecast, 2021 - 2033 (USD Million)
Fig. 50 Japan Market Estimates and Forecast, 2021 - 2033(USD Million)
Fig. 51 China Market Estimates and Forecast, 2021 - 2033 (USD Million)
Fig. 52 India Market Estimates and Forecast, 2021 - 2033 (USD Million)
Fig. 53 South Korea Market Estimates and Forecast, 2021 - 2033 (USD Million)
Fig. 54 Australia Market Estimates and Forecast, 2021 - 2033 (USD Million)
Fig. 55 Thailand Market Estimates and Forecast, 2021 - 2033 (USD Million)
Fig. 56 Latin America Market Estimates and Forecast, 2021 - 2033 (USD Million)
Fig. 57 Brazil Market Estimates and Forecast, 2021 - 2033 (USD Million)
Fig. 58 Argentina Market Estimates and Forecast, 2021 - 2033 (USD Million)
Fig. 59 MEA Market Estimates and Forecast, 2021 - 2033 (USD Million)
Fig. 60 South Africa Market Estimates and Forecast, 2021 - 2033 (USD Million)
Fig. 61 Saudi Arabia Market Estimates and Forecast, 2021 - 2033 (USD Million)
Fig. 62 UAE Market Estimates and Forecast, 2021 - 2033 (USD Million)
Fig. 63 Kuwait Market Estimates and Forecast, 2021 - 2033 (USD Million)
Fig. 64 Strategy framework

Newborn Screening Market Size, Share & Trends Analysis Report By Product, By Technology, By Test Type, By Region, and Segment Forecasts, 2025 - 2033

Description

Table of Contents

List of Tables

Newborn Screening Market Summary

Table of Contents

Chapter 1. Newborn Screening Market: Methodology and Scope

Chapter 2. Newborn Screening Market: Executive Summary

Chapter 3. Newborn Screening Market Variables, Trends, & Scope

Chapter 4. Newborn Screening Market: Product Estimates & Trend Analysis

Chapter 5. Newborn Screening Market: Technology Estimates & Trend Analysis

Chapter 6. Newborn Screening Market: Test Type Estimates & Trend Analysis

Chapter 7. Newborn Screening Market: Regional Business Analysis

Chapter 8. Competitive Landscape

List of Tables

List of Figures